Catherine Quinlan

1.7k total citations
55 papers, 936 citations indexed

About

Catherine Quinlan is a scholar working on Nephrology, Genetics and Molecular Biology. According to data from OpenAlex, Catherine Quinlan has authored 55 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Nephrology, 18 papers in Genetics and 17 papers in Molecular Biology. Recurrent topics in Catherine Quinlan's work include Renal Diseases and Glomerulopathies (18 papers), Renal and related cancers (16 papers) and Genomics and Rare Diseases (7 papers). Catherine Quinlan is often cited by papers focused on Renal Diseases and Glomerulopathies (18 papers), Renal and related cancers (16 papers) and Genomics and Rare Diseases (7 papers). Catherine Quinlan collaborates with scholars based in Australia, United Kingdom and United States. Catherine Quinlan's co-authors include Andrew J. Mallett, Melissa H. Little, Kynan T. Lawlor, Sara E. Howden, Chirag Patel, Belinda Phipson, Sean B. Wilson, Lorna J. Hale, Alicia Oshlack and Zornitza Stark and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Catherine Quinlan

51 papers receiving 928 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Quinlan Australia 14 446 282 213 166 143 55 936
Katherine Twombley United States 15 226 0.5× 475 1.7× 201 0.9× 125 0.8× 108 0.8× 53 842
Kyoung Hee Han South Korea 19 259 0.6× 348 1.2× 59 0.3× 144 0.9× 100 0.7× 74 1.0k
Ayman Refaie Egypt 18 244 0.5× 92 0.3× 113 0.5× 116 0.7× 422 3.0× 72 921
Mysore K. Phanish United Kingdom 16 369 0.8× 293 1.0× 55 0.3× 99 0.6× 161 1.1× 28 1000
Catherine Glastre France 11 109 0.2× 168 0.6× 98 0.5× 70 0.4× 129 0.9× 15 908
Ogo Egbuna United States 18 291 0.7× 553 2.0× 125 0.6× 127 0.8× 230 1.6× 37 1.3k
Richard W. Kim United States 14 579 1.3× 519 1.8× 167 0.8× 328 2.0× 283 2.0× 25 1.6k
Donna Hefferton Canada 18 482 1.1× 316 1.1× 651 3.1× 180 1.1× 112 0.8× 21 1.2k
Sofia Feinstein Israel 18 543 1.2× 441 1.6× 156 0.7× 281 1.7× 105 0.7× 33 1.1k
Choni Rinat Israel 18 498 1.1× 439 1.6× 151 0.7× 358 2.2× 106 0.7× 39 1.1k

Countries citing papers authored by Catherine Quinlan

Since Specialization
Citations

This map shows the geographic impact of Catherine Quinlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Quinlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Quinlan more than expected).

Fields of papers citing papers by Catherine Quinlan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Quinlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Quinlan. The network helps show where Catherine Quinlan may publish in the future.

Co-authorship network of co-authors of Catherine Quinlan

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Quinlan. A scholar is included among the top collaborators of Catherine Quinlan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Quinlan. Catherine Quinlan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Cheng, Lin, et al.. (2025). Optimising the mainstreaming of renal genomics: Complementing empirical and theoretical strategies for implementation. European Journal of Human Genetics. 33(3). 351–359. 2 indexed citations
4.
Quinlan, Catherine, et al.. (2024). Noninvasive pediatric blood pressure assessment: exploring the clinicians’ perspective. Blood Pressure Monitoring. 29(3). 127–135. 2 indexed citations
5.
Larkins, Nicholas, Catherine S. Choong, Markus P. Schlaich, et al.. (2024). Defining childhood hypertension: is it too complicated? An evaluation of the potential impact of different approaches in an Australian paediatric population. Journal of Hypertension. 42(11). 1932–1939. 1 indexed citations
6.
Cheng, Daryl R., et al.. (2023). Clinical and diagnostic utility of genomic sequencing for children referred to a Kidney Genomics Clinic with microscopic haematuria. Pediatric Nephrology. 38(8). 2623–2630. 11 indexed citations
7.
Wu, You, Kushani Jayasinghe, Zornitza Stark, et al.. (2023). Genomic testing for suspected monogenic kidney disease in children and adults: A health economic evaluation. Genetics in Medicine. 25(11). 100942–100942. 13 indexed citations
8.
Dorison, Aude, Irene M. Ghobrial, Thomas Forbes, et al.. (2022). Kidney Organoids Generated Using an Allelic Series of NPHS2 Point Variants Reveal Distinct Intracellular Podocin Mistrafficking. Journal of the American Society of Nephrology. 34(1). 88–109. 12 indexed citations
9.
Quinlan, Catherine & Michelle N. Rheault. (2022). X-Linked Kidney Disorders in Women. Seminars in Nephrology. 42(2). 114–121. 7 indexed citations
11.
Jayasinghe, Kushani, You Wu, Zornitza Stark, et al.. (2021). Cost-Effectiveness of Targeted Exome Analysis as a Diagnostic Test in Glomerular Diseases. Kidney International Reports. 6(11). 2850–2861. 27 indexed citations
12.
Apelt, Katja, Susan M. White, Jung-Eun Yeo, et al.. (2020). ERCC1mutations impede DNA damage repair and cause liver and kidney dysfunction in patients. The Journal of Experimental Medicine. 218(3). 24 indexed citations
13.
Jayasinghe, Kushani, Zornitza Stark, Chirag Patel, et al.. (2019). Comprehensive evaluation of a prospective Australian patient cohort with suspected genetic kidney disease undergoing clinical genomic testing: a study protocol. BMJ Open. 9(8). e029541–e029541. 12 indexed citations
14.
Quinlan, Catherine. (2019). CUBN variants uncouple proteinuria from kidney function. Nature Reviews Nephrology. 16(3). 135–136. 4 indexed citations
15.
Mallett, Andrew J., Catherine Quinlan, Chirag Patel, et al.. (2019). Precision Medicine Diagnostics for Rare Kidney Disease: Twitter as a Tool in Clinical Genomic Translation. Kidney Medicine. 1(5). 315–318. 5 indexed citations
16.
Little, Melissa H. & Catherine Quinlan. (2019). Advances in our understanding of genetic kidney disease using kidney organoids. Pediatric Nephrology. 35(6). 915–926. 9 indexed citations
17.
Forbes, Thomas, Sara E. Howden, Kynan T. Lawlor, et al.. (2018). Patient-iPSC-Derived Kidney Organoids Show Functional Validation of a Ciliopathic Renal Phenotype and Reveal Underlying Pathogenetic Mechanisms. The American Journal of Human Genetics. 102(5). 816–831. 155 indexed citations
18.
Hale, Lorna J., Sara E. Howden, Belinda Phipson, et al.. (2018). 3D organoid-derived human glomeruli for personalised podocyte disease modelling and drug screening. Nature Communications. 9(1). 5167–5167. 169 indexed citations
19.
Quinlan, Catherine, Jameela A. Kari, Clarissa Pilkington, et al.. (2015). The vascular phenotype of children with systemic lupus erythematosus. Pediatric Nephrology. 30(8). 1307–1316. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026